Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain

Virology

Volumn 284, Issue 1, 2001, Pages 99-112

  Kawano, Mitsuo ^a   Kaito, Masahiko ^a   Kozuka, Yuji ^a   Komada, Hiroshi ^a,b   Noda, Naoya ^a   Nanba, Kazuyoshi ^a   Tsurudome, Masato ^a   Ito, Morihiro ^a   Nishio, Machiko ^a   Ito, Yasuhiko ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYSTEINE DERIVATIVE; INTERFERON; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN V;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSFECTION; MOLECULAR CLONING; MORPHOGENESIS; NONHUMAN; PARAINFLUENZA VIRUS 2; PRIORITY JOURNAL; PROMOTER REGION; RNA VIRUS INFECTION; VACCINIA VIRUS; VERO CELL; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS RESISTANCE;

VACCINIA; VACCINIA VIRUS;

EID: 0035947275     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.0864     Document Type: Article

References (53)

1. Calain P., Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:1993;4822-4830.
2. Cattaneo R., Kaelin K., Baczko K., Billeter M. A. Measles virus editing provides an additional cysteine-rich protein. Cell. 56:1989;759-764.
3. Clarke D. K., Sidhu M. S., Jhonson J. E., Udem S. A. Rescue of mumps virus from cDNA. J. Virol. 74:2000;4831-4838.
4. Collins P. L., Hill M. G., Camargo E., Grosfeld H., Chanok R. M., Murphy B. R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
5. Didcock L., Young D. F., Goodbourn S., Randall R. E. The V protein of simian virus 5 inhibits interferon signaling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73:1999;9928-9933.
6. Durbin A. P., Hall S. L., Siew J. W., Whitehead S. S., Collins P. L., Murphy B. R. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology. 235:1997;323-332.
7. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
8. Garcin D., Ito M., Kolakofsky D. A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology. 238:1997;424-431.
9. Garcin D., Pelet T., Calain P., Roux L., Curran J., Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus. EMBO J. 14:1995;6087-6094.
10. Giorgi C., Blumberg B. M., Kolakofsky D. Sendai virus contains overlapping genes expressed from a single mRNA. Cell. 35:1983;829-836.
11. Gotoh B., Takeuchi K., Komatsu T., Yokoo J., Kimura Y., Kurotani A., Kato A., Nagai Y. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-α/β-mediated responses. FEBS Lett. 459:1999;205-210.
12. Hasan M. K., Kato A., Muranaka M., Yamaguchi R., Sakai Y., Hatano I., Tashiro M., Nagai Y. Versatility of the accessory C proteins of Sendai virus: Contribution to virus assembly as an additional role. J. Virol. 74:2000;5619-5628.
13. He B., Paterson R. G., Ward C. D., Lamb R. A. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology. 237:1997;249-260.
14. Hoffman M. A., Banerjee A. K. An infectious clone of human parainfluenza virus type 3. J. Virol. 71:1997;4272-4277.
15. Ito Y., Kimura Y., Nagata I., Kunii A. Effects of L-glutamine deprivation on growth of HVJ (Sendai virus) in BHK cells. J. Virol. 13:1974;557-566.
16. Ito Y., Tsurudome M., Hishiyama M., Yamada A. Immunological interrelationships among human and non-human paramyxoviruses revealed by immunoprecipitation. J. Gen. Virol. 68:1987;1289-1297.
17. Kato A., Kiyotani K., Sakai Y., Yoshida T., Nagai Y. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:1997;578-587.
18. Kato A., Sakai Y., Shioda T., Kondo T., Nakanishi M., Nagai Y. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells. 1:1996;569-579.
19. Kawano M., Bando H., Ohgimoto S., Kondo K., Tsurudome M., Nishio M., Ito Y. Sequence of the fusion protein gene of human parainfluenza type 2 virus and its 3′ intergenic region: Lack of small hydrophobic (SH) gene. Virology. 178:1990a;289-292.
20. Kawano M., Bando H., Ohgimoto S., Okamoto K., Kondo K., Tsurudome M., Nishio M., Ito Y. Complete nucleotide sequence of matrix gene of human parainhfluenza type 2 virus and expression of the M protein in bacteria. Virology. 179:1990b;857-861.
21. Kawano M., Bando H., Yuasa T., Kondo K., Tsurudome M., Komada H., Nishio M., Ito Y. Sequence determination of the hemagglutinin-neuraminidase (HN) gene of human parainfluenza type 2 virus and construction of a phylogenetic tree for HN proteins of all the paramyxoviruses that are infectious to humans. Virology. 174:1990c;308-313.
22. Kawano M., Okamoto K., Bando H., Kondo K., Tsurudome M., Komada H., Nishio M., Ito Y. Characterizations of the human parainfluenza type2 virus gene encoding the L protein and the intergenic sequenses. Nucleic Acids Res. 19:1991;2739-2746.
23. Kawano M., Tsurudome M., Oki N., Nishio M., Komada H., Matsumura H., Kusagawa S., Ohta H., Ito Y. Sequence determination of the P gene of simian virus 41: Presence of irregular deletions near the RNA-editing sites of paramyxoviruses. J. Gen. Virol. 74:1993;911-916.
24. Kondo K., Bando H., Tsurudome M., Kawano M., Nishio M., Ito Y. Sequence analysis of the phosphoprotein (P) genes of human parainfluenza type 4A and 4B viruses and RNA editing at transcript of the P genes: The number of G residues added is imprecise. Virology. 178:1990;321-326.
25. Kretzschmar E., Peluso R., Schnell M. J., Whitt M. A., Rose J. K. Normal replication of vesicular stomatitis virus without C proteins. Virology. 216:1996;309-316.
26. Kurotani A., Kiyotani K., Kato A., Shioda T., Sakai Y., Mizumoto K., Yoshida T., Nagai Y. The paramyxovirus, Sendai virus, C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells. 2:1998;111-124.
27. Lamb R. A., Choppin P. W. The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides. Virology. 81:1977;371-381.
28. Lawson N., Stillman E., Whitt M., Rose J. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA. 92:1995;4471-4481.
29. Lin G. Y., Paterson R. G., Richardson C. D., Lamb R. A. The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology. 249:1998;189-200.
30. Lin G. Y., Lamb R. A. The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J. Virol. 74:2000;9152-9166.
31. Matsuoka Y., Curran J., Pelet T., Kolakofsky D., Ray R., Compans R. W. The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J. Virol. 65:1991;3406-3410.
32. Murphy S. K., Parks G. D. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Virology. 232:1997;145-157.
33. Nishio M., Tsurudome M., Ito M., Kawano M., Kusagawa S., Komada H., Ito Y. Isolation of monoclonal antibodies directed against the V protein of human parainfluenzavirus type 2 and localization of the V protein in virus-infected cells. Med. Microbiol. Immunol. 188:1999;79-82.
34. Nishio M., Tsurudome M., Ito M., Watanabe N., Kawano M., Komada H., Ito Y. Human parainfluenza virus type 2 phosphoprotein: Mapping of monoclonal antibody epitopes and location of the multimerization domain. J. Gen. Virol. 78:1997;1303-1308.
35. Nishio M., Tsurudome M., Kawano M., Ohgimoto S., Ito M., Komada H., Ito Y. Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: One of the two NP binding sites on P is essential for granule formation. J. Gen. Virol. 77:1996;2457-2463.
36. Ohgimoto S., Bando H., Kawano M., Okamoto K., Kondo K., Tsurudome M., Nishio M., Ito Y. Sequence analysis of P gene of human parainfluenza type 2 virus: P and cysteine-rich proteins are translated by two mRNAs that differ by two non-templated G residues. Virology. 177:1990;116-123.
37. Paterson R. G., Lamb R. A. RNA editing by G-nucleotide insertion in Mumps virus P-gene mRNA transcripts. J. Virol. 64:1990;4137-4145.
38. Pattnaik A. K., Ball L. A., LeGrone A. W., Wertz G. W. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell. 69:1992;1011-1020.
39. Peeters B. P., de. Leeuw O. S., Koch G., Gielkens A. L. Rescue of Newcastle disease virus from cloned cDNA: Evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73:1999;5001-5009.
40. Radecke F., Billeter M. A. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology. 217:1996;418-421.
41. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dotsch C., Christiansen G., Billeter M. A. Rescue of measles viruses from cloned DNA. EMBO J. 14:1995;5773-5784.
42. Schnell M. J., Mebatsion T., Conzelmann K.-K. Infectious rabies viruses from cloned cDNA. EMBO J. 13:1994;4195-4203.
43. Spriggs M., Collins P. L. Sequence analysis of the P and C protein genes of human parainfluenza virus type 3: Patterns of amino acid sequence homology among paramyxovirus proteins. J. Gen. Virol. 67:1986;2705-2719.
44. Steffan N. H., Henry D. H., Robert M. H., Jeffrey K. P., Larry R. P. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:1989;51-59.
45. Sutter G., Ohlmann M., Erfle V. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett. 371:1995;9-12.
46. Thomas S. M., Lamb R. A., Paterson R. G. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV 5. Cell. 54:1988;891-902.
47. Tsurudome M., Nishio M., Komada H., Bando H., Ito Y. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Virology. 171:1989;38-48.
48. Vidal S., Curran J., Kolakofsky D. Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J. Virol. 64:1990;239-246.
49. Watanabe N., Kawano M., Tsurudome M., Kusagawa S., Nishio M., Komada H., Shima T., Ito Y. Identification of sequence responsible for nuclear targeting of the V protein of human parainfluenza virus type 2. J. Gen. Virol. 77:1996;327-338.
50. Whelan S. P., Ball L. A., Barr J. N., Wertz G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA. 92:1995;8388-8392.
51. Wyatt L. S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology. 210:1995;202-205.
52. Young D. F., Didcock L., Goodbourn S., Randall R. E. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology. 269:2000;383-390.
53. Yuasa T., Bando H., Kawano M., Tsurudome M., Nishio M., Kondo K., Komada H., Ito Y. Sequence analysis of the 3′ genome end and NP gene of human parainfluensa type 2 virus: Sequence variation of the gene-starting signal and the conserved 3′ end. Virology. 179:1990;777-784.